Redwood Scientific Technologies, Inc. develops and markets homeopathic products which feature oral strip delivery technology. The company is headquartered in Albany, New York. The company went IPO on 2008-03-12. RST utilizes Patent-pending, sublingual strip delivery technology that enhances bioavailability. The main product, Prolongz, is designed to treat premature ejaculation in men. Prolongz has been registered with the FDA #079526408, allowing Redwood to elevate ourselves from competitors. Redwoods Prolongz is on course to establish ourselves as the industry leader for the adult male sexual performance dysfunction market through our membership (subscription) model. The firm is aggressively expanding our customer population through heavy investments in national cable television commercials and infomercials which also drives consumer awareness and retail sales. Source: Crunchbase
Redwood Scientific Technologies Inc의 주요 재무제표는 무엇인가요?
최신 재무제표(Form-10K)에 따르면, Nuveen Minnesota Quality Municipal Income Fund의 총 자산은 $0이며, 순손실입니다.
RSCI의 주요 재무 비율은 무엇인가요?
Nuveen Minnesota Quality Municipal Income Fund의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Redwood Scientific Technologies Inc의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Nuveen Minnesota Quality Municipal Income Fund 주요 수익원은 Hyper-immune Products이며, 최신 수익 발표에서 수익은 7,287,002입니다. 지역별로는 Australia이 Nuveen Minnesota Quality Municipal Income Fund의 주요 시장이며, 수익은 5,249,960입니다.
Redwood Scientific Technologies Inc은 수익성이 있나요?
no, 최신 재무제표에 따르면 Nuveen Minnesota Quality Municipal Income Fund의 순손실은 $0입니다.
Redwood Scientific Technologies Inc에 부채가 있나요?
no, Nuveen Minnesota Quality Municipal Income Fund의 부채는 0입니다.
Redwood Scientific Technologies Inc의 발행 주식은 몇 주인가요?
Nuveen Minnesota Quality Municipal Income Fund의 총 발행 주식은 0주입니다.